High Tower Advisors, LLC Biond Vax Pharmaceuticals Ltd. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$2.5 - $40.97 $44,750 - $733,363	-17,900 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$23.7 - $51.1 $29,862 - $64,386	-1,260 Reduced 6.58%	17,900 $701,000
Q2 2020 Aug 10, 2020	BUY	$7.2 - $24.87 $1,620 - $5,595	225 Added 1.19%	19,160 $435,000
Q1 2020 May 21, 2020	BUY	$5.36 - $11.65 $11,443 - $24,872	2,135 Added 12.71%	18,935 $146,000
Q4 2017 Feb 14, 2018	BUY	$4.73 - $7.78 $79,464 - $130,704	16,800	16,800 $91,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.